• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口服贝沙罗汀单药成功治疗表现为获得性鱼鳞病的原发性皮肤外周T细胞淋巴瘤

Successful Treatment of Primary Cutaneous Peripheral T-Cell Lymphoma Presenting Acquired Ichthyosis with Oral Bexarotene Monotherapy.

作者信息

Tanita Kayo, Fujimura Taku, Sato Yota, Hidaka Takanori, Furudate Sadanori, Kambayashi Yumi, Tsukada Akira, Hashimoto Akira, Aiba Setsuya

机构信息

Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.

出版信息

Case Rep Oncol. 2017 Apr 6;10(1):328-332. doi: 10.1159/000468981. eCollection 2017 Jan-Apr.

DOI:10.1159/000468981
PMID:28512419
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5422724/
Abstract

Acquired ichthyosis (AI) is a reactive cutaneous manifestation that can be associated with malignant hematological disease, including cutaneous T-cell lymphoma (CTCL). Since it is difficult to distinguish AI from ichthyosiform mycosis fungoides, to select the treatment for CTCL with ichthyosis-like appearance and to evaluate its efficacy is sometimes challenging. In this report, we describe a case of primary cutaneous peripheral T-cell lymphoma not otherwise specified presenting AI successfully treated with oral bexarotene. In the present case, the administration of oral bexarotene was not only effective for lymphoma cells infiltrating ulcers and nodules, but it also eliminated AI.

摘要

获得性鱼鳞病(AI)是一种反应性皮肤表现,可与恶性血液系统疾病相关,包括皮肤T细胞淋巴瘤(CTCL)。由于难以将AI与蕈样肉芽肿性鱼鳞病相区分,因此对于具有鱼鳞病样外观的CTCL选择治疗方法并评估其疗效有时具有挑战性。在本报告中,我们描述了一例原发性皮肤外周T细胞淋巴瘤(未另行分类)伴AI的病例,该病例通过口服贝沙罗汀成功治愈。在本病例中,口服贝沙罗汀不仅对浸润溃疡和结节的淋巴瘤细胞有效,还消除了AI。

相似文献

1
Successful Treatment of Primary Cutaneous Peripheral T-Cell Lymphoma Presenting Acquired Ichthyosis with Oral Bexarotene Monotherapy.口服贝沙罗汀单药成功治疗表现为获得性鱼鳞病的原发性皮肤外周T细胞淋巴瘤
Case Rep Oncol. 2017 Apr 6;10(1):328-332. doi: 10.1159/000468981. eCollection 2017 Jan-Apr.
2
Successful Treatment of Advanced Primary Cutaneous Peripheral T-Cell Lymphoma with Oral Bexarotene Monotherapy.口服贝沙罗汀单药成功治疗晚期原发性皮肤外周T细胞淋巴瘤
Case Rep Oncol. 2018 Mar 28;11(1):212-215. doi: 10.1159/000488236. eCollection 2018 Jan-Apr.
3
Comparison of the Efficacy and Safety of Bexarotene and Photo(Chemo)Therapy Combination Therapy and Bexarotene Monotherapy for Cutaneous T-Cell Lymphoma.贝沙罗汀与光(化学)疗法联合治疗和贝沙罗汀单药治疗皮肤T细胞淋巴瘤的疗效与安全性比较。
Dermatol Ther (Heidelb). 2022 Mar;12(3):615-629. doi: 10.1007/s13555-021-00655-0. Epub 2022 Jan 27.
4
Oral bexarotene for post-transplant cutaneous T-cell lymphoma.口服贝沙罗汀治疗移植后皮肤 T 细胞淋巴瘤。
Dermatol Ther. 2017 Sep;30(5). doi: 10.1111/dth.12524. Epub 2017 Jul 26.
5
Ichthyosiform eruptions in association with primary cutaneous T-cell lymphomas.
Br J Dermatol. 2009 Jul;161(1):115-20. doi: 10.1111/j.1365-2133.2009.09109.x. Epub 2009 Mar 26.
6
Evaluation of the efficacy of the combination of oral bexarotene and methotrexate for the treatment of early stage treatment-refractory cutaneous T-cell lymphoma.评估口服贝沙罗汀与甲氨蝶呤联合治疗早期治疗难治性皮肤T细胞淋巴瘤的疗效。
J Dermatolog Treat. 2009;20(3):169-76. doi: 10.1080/09546630802562427.
7
Polish Lymphoma Research Group Experience With Bexarotene in the Treatment of Cutaneous T-Cell Lymphoma.波兰淋巴瘤研究小组使用贝沙罗汀治疗皮肤T细胞淋巴瘤的经验。
Am J Ther. 2016 May-Jun;23(3):e749-56. doi: 10.1097/MJT.0000000000000056.
8
Optimizing bexarotene therapy for cutaneous T-cell lymphoma.优化贝沙罗汀治疗皮肤T细胞淋巴瘤的方案。
J Am Acad Dermatol. 2002 Nov;47(5):672-84. doi: 10.1067/mjd.2002.124607.
9
Full clinical recovery after topical acyclovir treatment of Epstein-Barr virus associated cutaneous B-cell lymphoma in patient with mycosis fungoides.蕈样肉芽肿患者的爱泼斯坦-巴尔病毒相关皮肤B细胞淋巴瘤经局部用阿昔洛韦治疗后实现完全临床康复。
Croat Med J. 2005 Jun;46(3):458-62.
10
Absence of modulation of CD4+CD25 regulatory T cells in CTCL patients treated with bexarotene.贝沙罗汀治疗 CTCL 患者时 CD4+CD25 调节性 T 细胞无调节作用。
Exp Dermatol. 2010 Aug;19(8):e95-102. doi: 10.1111/j.1600-0625.2009.00993.x.

引用本文的文献

1
Coexistence of T-Cell Lymphoblastic Lymphoma and Ichthyosis Vulgaris: A Case Report.T 细胞淋巴母细胞淋巴瘤与寻常型鱼鳞病并存:一例报告
Case Rep Oncol Med. 2025 Jan 29;2025:5023552. doi: 10.1155/crom/5023552. eCollection 2025.
2
Adult-Onset Acquired Ichthyosis Revealing an Underlying Colon Adenocarcinoma.成人起病的获得性鱼鳞病揭示潜在的结肠腺癌
Cureus. 2024 Nov 5;16(11):e73045. doi: 10.7759/cureus.73045. eCollection 2024 Nov.
3
Regulation of HDAC11 gene expression in early myogenic differentiation.调控早期成肌分化中 HDAC11 基因的表达。

本文引用的文献

1
Tumor-associated M2 macrophages in mycosis fungoides acquire immunomodulatory function by interferon alpha and interferon gamma.蕈样肉芽肿中肿瘤相关的M2巨噬细胞通过α干扰素和γ干扰素获得免疫调节功能。
J Dermatol Sci. 2016 Sep;83(3):182-9. doi: 10.1016/j.jdermsci.2016.05.004. Epub 2016 Jun 8.
2
Tumor-associated macrophages in skin: How to treat their heterogeneity and plasticity.皮肤中的肿瘤相关巨噬细胞:如何应对其异质性和可塑性。
J Dermatol Sci. 2016 Sep;83(3):167-73. doi: 10.1016/j.jdermsci.2016.05.015. Epub 2016 May 25.
3
The possible interaction between periostin expressed by cancer stroma and tumor-associated macrophages in developing mycosis fungoides.
PeerJ. 2023 Aug 30;11:e15961. doi: 10.7717/peerj.15961. eCollection 2023.
4
Acquired ichthyosis: a clinical review.获得性鱼鳞病:临床综述。
Arch Dermatol Res. 2023 Nov;315(9):2529-2543. doi: 10.1007/s00403-023-02668-5. Epub 2023 Jul 9.
5
Successful Treatment of Advanced Primary Cutaneous Peripheral T-Cell Lymphoma with Oral Bexarotene Monotherapy.口服贝沙罗汀单药成功治疗晚期原发性皮肤外周T细胞淋巴瘤
Case Rep Oncol. 2018 Mar 28;11(1):212-215. doi: 10.1159/000488236. eCollection 2018 Jan-Apr.
6
Ichthyosis: A Harbinger of Lymphoma.鱼鳞病:淋巴瘤的先兆
BMJ Case Rep. 2018 Apr 10;2018:bcr-2018-224229. doi: 10.1136/bcr-2018-224229.
蕈样肉芽肿发展过程中癌基质表达的骨膜蛋白与肿瘤相关巨噬细胞之间可能的相互作用。
Exp Dermatol. 2016 Feb;25(2):107-12. doi: 10.1111/exd.12873. Epub 2015 Nov 23.
4
The utility of bexarotene in mycosis fungoides and Sézary syndrome.贝沙罗汀在蕈样肉芽肿和赛泽里综合征中的应用。
Onco Targets Ther. 2015 Feb 3;8:367-73. doi: 10.2147/OTT.S61308. eCollection 2015.
5
Depletion of M2-like tumor-associated macrophages delays cutaneous T-cell lymphoma development in vivo.耗竭 M2 样肿瘤相关巨噬细胞可延缓体内皮肤 T 细胞淋巴瘤的发展。
J Invest Dermatol. 2014 Nov;134(11):2814-2822. doi: 10.1038/jid.2014.206. Epub 2014 Apr 29.
6
Ichthyosiform eruptions in association with primary cutaneous T-cell lymphomas.
Br J Dermatol. 2009 Jul;161(1):115-20. doi: 10.1111/j.1365-2133.2009.09109.x. Epub 2009 Mar 26.
7
Bexarotene blunts malignant T-cell chemotaxis in Sezary syndrome: reduction of chemokine receptor 4-positive lymphocytes and decreased chemotaxis to thymus and activation-regulated chemokine.贝沙罗汀可抑制蕈样肉芽肿中恶性T细胞的趋化作用:趋化因子受体4阳性淋巴细胞数量减少,对胸腺和活化调节趋化因子的趋化作用降低。
Am J Hematol. 2007 Sep;82(9):792-7. doi: 10.1002/ajh.20952.
8
Biological effects of bexarotene in cutaneous T-cell lymphoma.贝沙罗汀在皮肤T细胞淋巴瘤中的生物学效应。
Arch Dermatol. 2005 Mar;141(3):315-21. doi: 10.1001/archderm.141.3.315.
9
Systemic treatment of psoriatic patients with bexarotene decreases epidermal proliferation and parameters for inflammation, and improves differentiation in lesional skin.用贝沙罗汀对银屑病患者进行全身治疗可降低表皮增殖和炎症参数,并改善皮损皮肤的分化。
J Am Acad Dermatol. 2004 Aug;51(2):257-64. doi: 10.1016/j.jaad.2004.03.002.
10
Ichthyosiform mycosis fungoides: an atypical variant of cutaneous T-cell lymphoma.鱼鳞癣样蕈样肉芽肿:皮肤T细胞淋巴瘤的一种非典型变体。
J Am Acad Dermatol. 2004 Mar;50(3):368-74. doi: 10.1016/j.jaad.2003.10.003.